iBio, Inc. Purchase Agreements
13 Contracts & Agreements
- Purchase and Sale Agreement, dated as of May 17, 2024, by and between iBio CDMO LLC and The Board of Regents of the Texas A&M University System (Filed With SEC on May 20, 2024)
- Form of Securities Purchase Agreement, dated March 26, 2024, by and between iBio, Inc. and the Purchaser signatory thereto (Filed With SEC on April 1, 2024)
- Asset Purchase Agreement, dated February 25, 2024, by and between iBio, Inc. and Otsuka Pharmaceutical Co., Ltd (Filed With SEC on February 26, 2024)
- Form of Securities Purchase Agreement, dated December 5, 2023, between iBio, Inc. and the purchasers named on the signature pages thereto (Filed With SEC on December 6, 2023)
- Form of Securities Purchase Agreement to be entered into in this Offering (Filed With SEC on November 30, 2023)
- Purchase and Sale Agreement, dated September 15, 2023, by and between iBio CDMO LLC and Majestic Realty Co (Filed With SEC on September 21, 2023)
- Purchase Agreement, dated as of August 4 2023, by and between iBio, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on August 4, 2023)
- Asset Purchase Agreement, dated September 16, 2022, by and between iBio, Inc. and Rubryc Therapeutics, Inc (Filed With SEC on September 21, 2022)
- Equity Purchase Agreement dated November 1, 2021 by and between Bryan Capital Investors LLC and iBio, Inc (Filed With SEC on November 4, 2021)
- Purchase and Sale Agreement, dated November 1, 2021, by and among College Station Investors LLC, Bryan Capital Investors LLC, iBio CDMO LLC and iBio, Inc (Filed With SEC on November 4, 2021)
- Purchase Agreement, dated as of May 13, 2020, between iBio, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on May 14, 2020)
- Purchase Agreement, dated March 19, 2020, between the Company and Lincoln Park Capital Fund, LLC (Filed With SEC on March 20, 2020)
- PURCHASE AGREEMENT (Filed With SEC on July 24, 2017)
